358 filings
Page 5 of 18
8-K
md162dctdkl
6 May 21
Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
4:09pm
8-K
3q3qwbxgmbgra7r96yx9
26 Apr 21
Entry into a Material Definitive Agreement
12:00am
424B3
5o3xp 58sh
23 Apr 21
Prospectus supplement
5:30pm
424B5
x8mjaz3kmo78y4ro8e
23 Apr 21
Prospectus supplement for primary offering
5:28pm
S-8
3r8jb8d6pp aqx1ro4jc
26 Mar 21
Registration of securities for employees
4:22pm
8-K
rm9gqivq gxgksf0
25 Mar 21
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates
4:06pm
8-K
pyh 78h45bi
20 Jan 21
Departure of Directors or Certain Officers
8:01am
8-K
eey60065t7t
4 Jan 21
Amendments to Articles of Incorporation or Bylaws
4:16pm
424B5
xb9zdj lp
23 Dec 20
Prospectus supplement for primary offering
5:05pm
EFFECT
hdc8dtr 4z
23 Dec 20
Notice of effectiveness
12:15am
CORRESP
tclug3
21 Dec 20
Correspondence with SEC
12:00am
UPLOAD
1k7bzs5 20
21 Dec 20
Letter from SEC
12:00am
UPLOAD
svzt p50w21f
18 Dec 20
Letter from SEC
12:00am
8-K
1cmd2hgd
17 Dec 20
Entry into a Material Definitive Agreement
7:07am
424B5
gssncknntj9t
11 Dec 20
Prospectus supplement for primary offering
4:46pm